Miklos Kaplar
Overview
Explore the profile of Miklos Kaplar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esze R, Barna S, Fulop P, Kempler P, Miko M, Pall D, et al.
Diabetol Metab Syndr
. 2024 Aug;
16(1):211.
PMID: 39210480
Background: In order to investigate microvascular complications in metabolic diseases, we aimed to investigate cerebral and peripheral microcirculation in relation to peripheral neuropathy and laboratory biomarkers in type 2 diabetes...
2.
Esze R, Balkay L, Barna S, Szatmarine Egeresi L, Emri M, Pall D, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792441
: Since metabolic diseases and atherosclerotic vascular events are firmly associated, herein we investigate changes in central microcirculation and atherosclerosis-related body fat distribution in patients with type 2 diabetes mellitus...
3.
Vadadokhau U, Varga I, Kaplar M, Emri M, Csosz E
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732002
The escalating prevalence of metabolic disorders, notably type 2 diabetes (T2D) and obesity, presents a critical global health challenge, necessitating deeper insights into their molecular underpinnings. Our study integrates proteomics...
4.
Topological dissimilarities of hierarchical resting networks in type 2 diabetes mellitus and obesity
Aranyi S, Kepes Z, Nagy M, Opposits G, Garai I, Kaplar M, et al.
J Comput Neurosci
. 2022 Sep;
51(1):71-86.
PMID: 36056275
Type 2 diabetes mellitus (T2DM) is reported to cause widespread changes in brain function, leading to cognitive impairments. Research using resting-state functional magnetic resonance imaging data already aims to understand...
5.
Nokhoijav E, Guba A, Kumar A, Kunkli B, Kallo G, Kaplar M, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35562924
Metabolomics strategies are widely used to examine obesity and type 2 diabetes (T2D). Patients with obesity ( = 31) or T2D ( = 26) and sex- and age-matched controls (...
6.
Kepes Z, Aranyi C, Forgacs A, Nagy F, Kukuts K, Esze R, et al.
Hell J Nucl Med
. 2021 Dec;
24(3):222-227.
PMID: 34954784
Since hyperhomocysteinaemia (HHcys) is implicated as a risk factor for the development of neurodegeneration, and is associated with the development of metabolic diseases,we aimed at analysing the effect of homocysteine...
7.
Kepes Z, Miko M, Kukuts K, Esze R, Barna S, Somodi S, et al.
Acta Radiol
. 2021 Dec;
64(1):187-194.
PMID: 34894745
Background: Sensitive imaging modalities in the diagnosis of microcircular complications of the lower extremities induced by metabolic diseases are becoming a focus of interest. Purpose: To investigate the [Tc]HMPAO uptake...
8.
Toth N, Silver D, Balla S, Kaplar M, Csutak A
Graefes Arch Clin Exp Ophthalmol
. 2021 Jul;
259(11):3339-3350.
PMID: 34283292
Purposes: To examine corneal nerve and retinal nerve characteristics of participants with type 2 diabetes mellitus (T2DM) compared with obese participants without diabetes to discover potential nerve vulnerabilities. Methods: All...
9.
Kepes Z, Nagy F, Budai A, Barna S, Esze R, Somodi S, et al.
Nucl Med Rev Cent East Eur
. 2021 Feb;
24(1):11-15.
PMID: 33576479
Background: Cerebral blood flow abnormalities are supposed to be potential risk factors for developing cognitive dysfunction in the general population. Aging, obesity and type 2 diabetes mellitus are associated with...
10.
Fejes Z, Poliska S, Czimmerer Z, Kaplar M, Penyige A, Szabo G, et al.
Thromb Haemost
. 2016 Dec;
117(3):529-542.
PMID: 27975100
Megakaryocyte (MK)-derived miRNAs have been detected in platelets. Here, we analysed the expression of platelet and circulating miR-223, miR-26b, miR-126 and miR-140 that might be altered with their target mRNAs...